Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation

Aleyda Benitez-Amaro, Chiara Pallara, Laura Nasarre, Andrea Rivas-Urbina, Sonia Benitez, Angela Vea, Olga Bornachea, David de Gonzalo-Calvo, Gabriel Serra-Mir, Sandra Villegas, Roger Prades, José Luís Sanchez-Quesada, Cristina Chiva, Eduard Sabido, Teresa Tarragó, Vicenta Llorente-Cortés

Research output: Contribution to journalArticleResearch

1 Citation (Scopus)

Abstract

© 2019 Elsevier B.V. Aggregated LDL is the first ligand reported to interact with the cluster II CR9 domain of low-density lipoprotein receptor-related protein 1 (LRP1). In particular, the C-terminal half of domain CR9, comprising the region Gly 1127 -Cys 1140 exclusively recognizes aggregated LDL and it is crucial for aggregated LDL binding. Our aim was to study the effect of the sequence Gly 1127 -Cys 1140 (named peptide LP3 and its retro-enantio version, named peptide DP3)on the structural characteristics of sphingomyelinase- (SMase)and phospholipase 2 (PLA 2 )-modified LDL particles. Turbidimetry, gel filtration chromatography (GFC)and transmission electronic microscopy (TEM)analysis showed that LP3 and DP3 peptides strongly inhibited SMase- and PLA 2 -induced LDL aggregation. Nondenaturing polyacrylamide gradient gel electrophoresis (GGE), agarose gel electrophoresis and high-performance thin-layer chromatography (HPTLC)indicated that LP3 and DP3 prevented SMase-induced alterations in LDL particle size, electric charge and phospholipid content, respectively, but not those induced by PLA 2 . Western blot analysis showed that LP3 and DP3 counteracted changes in ApoB-100 conformation induced by the two enzymes. LDL proteomics (LDL trypsin digestion followed by mass spectroscopy)and computational modeling methods evidenced that peptides preserve ApoB-100 conformation due to their electrostatic interactions with a basic region of ApoB-100. These results demonstrate that LRP1-derived peptides are protective against LDL aggregation, even in conditions of extreme lipolysis, through their capacity to bind to ApoB-100 regions critical for ApoB-100 conformational preservation. These results suggests that these LRP1(CR9)derived peptides could be promising tools to prevent LDL aggregation induced by the main proteolytic enzymes acting in the arterial intima.
Original languageEnglish
Pages (from-to)1302-1316
JournalBiochimica et Biophysica Acta - Biomembranes
Volume1861
DOIs
Publication statusPublished - 1 Jul 2019

Keywords

  • ApoB-100
  • Lipoprotein aggregation
  • LRP1-derived peptides
  • SMase, PLA , atherosclerosis 2

Fingerprint Dive into the research topics of 'Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation'. Together they form a unique fingerprint.

  • Cite this

    Benitez-Amaro, A., Pallara, C., Nasarre, L., Rivas-Urbina, A., Benitez, S., Vea, A., Bornachea, O., de Gonzalo-Calvo, D., Serra-Mir, G., Villegas, S., Prades, R., Sanchez-Quesada, J. L., Chiva, C., Sabido, E., Tarragó, T., & Llorente-Cortés, V. (2019). Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation. Biochimica et Biophysica Acta - Biomembranes, 1861, 1302-1316. https://doi.org/10.1016/j.bbamem.2019.05.003